SOURCE: Enterprising Georgia

April 24, 2008 09:40 ET

Advances in Cancer Vaccines: An Enterprising Georgia Live Satellite Broadcast Event

ATLANTA, GA--(Marketwire - April 24, 2008) - Are life-saving cancer vaccines just around the corner? Enterprising Georgia, a joint venture of The MIT Enterprise Forum (MITEF) of Atlanta and the Georgia Research Alliance, will present "Next-generation Cancer Vaccines: Marshaling the Immune System to Fight Cancer" on Wednesday, April 30, 2008 at the Georgia Public Broadcasting auditorium. This live, on-site broadcast will be aired from Atlanta to MIT Enterprise Forum viewing sites worldwide and throughout the State of Georgia. Attendance is open to all and attendees will be part of the studio audience.

As science unravels the intricacies of the immune system, scientists are discovering new approaches to prevent, treat and cure cancer. Attendees will hear from scientists and business executives about the progress in cancer vaccines and how these discoveries are catapulting Georgia to a position of world leadership in what is expected to be a $24 billion market by 2010.

Expert speakers will also discuss how the first preventive cancer vaccine was developed for a difficult-to-reach population and what its impact has been; strategies for harnessing the immune system to fight cancer; and the choices and the scientific challenges for two of the world's largest vaccine companies -- Merck (human vaccines) and Merial (animal vaccines) -- in targeting cervical cancer and canine melanoma.

Speakers include Dr. John Ward of the CDC, who will present the story of the hepatitis B vaccine as the first cancer vaccine; Dr. Andrew Mellor, director and co-founder of the Immunotherapy Center at the Medical College of Georgia and a Georgia Research Alliance Eminent Scholar in Immunogenetics; Dr. Robert Nordgren of Merial, who will describe the development and approval process for their custom canine cancer vaccine and how animal vaccines serve as models for human vaccines; and Dr. Gregg Sylvester, senior medical director at Merck Vaccines and Infectious Diseases, who leads a team focusing on Merck's new cancer prevention vaccine. A moderated panel discussion will follow the presentations.

More Information

The meeting will be held at the Georgia Public Broadcasting Auditorium. Networking and a light dinner will begin at 5:45 pm; the broadcast will begin at 7 pm. This event will be a live broadcast.

Prices range from $25 for members of MITEF and TAG to $45 for non-member onsite registration; all students are $15. Program participation and membership are open to all, regardless of academic affiliation. Additional information is available at

About Enterprising Georgia

Enterprising Georgia is a joint venture of The MIT Enterprise Forum of Atlanta and the Georgia Research Alliance. Enterprising Georgia provides a series of broadcast events that explore business and technology challenges in areas of pressing importance worldwide, with emphasis on Georgia's role in meeting these challenges.

Contact Information